Department of Chemistry, Kansas State University, Manhattan, Kansas 66506, United States.
NASA Ames Research Center, Moffett Field, California 94035, United States.
ACS Sens. 2021 Oct 22;6(10):3621-3631. doi: 10.1021/acssensors.1c01175. Epub 2021 Sep 21.
Proteases are critical signaling molecules and prognostic biomarkers for many diseases including cancer. There is a strong demand for multiplex bioanalytical techniques that can rapidly detect the activity of extracellular proteases with high sensitivity and specificity. This study demonstrates an activity-based electrochemical biosensor of a 3 × 3 gold microelectrode array for the detection of cathepsin B activity in human serum diluted in a neutral buffer. Proteolysis of ferrocene-labeled peptide substrates functionalized on 200 × 200 μm microelectrodes is measured simultaneously over the nine channels by AC voltammetry. The protease activity is represented by the inverse of the exponential decay time constant (1/τ), which equals to (/)[CB] based on the Michaelis-Menten model. An enhanced activity of the recombinant human cathepsin B (rhCB) is observed in a low-ionic-strength phosphate buffer at pH = 7.4, giving a very low limit of detection of 8.49 × 10 s for activity and 57.1 pM for the active rhCB concentration that is comparable to affinity-based enzyme-linked immunosorbent assay (ELISA). The cathepsin B presented in the human serum sample is validated by ELISA, which mainly detects the inactive proenzyme, while the electrochemical biosensor specifically measures the active cathepsin B and shows significantly higher decay rates when rhCB and human serum are activated. Analyses of the kinetic electrochemical measurements with spiked active cathepsin B in human serum provide further assessment of the protease activity in the complex sample. This study lays the foundation to develop the gold microelectrode array into a multiplex biosensor for rapid detection of the activity of extracellular proteases toward cancer diagnosis and treatment assessment.
蛋白酶是许多疾病(包括癌症)的关键信号分子和预后生物标志物。人们强烈需要能够快速、高灵敏度和特异性地检测细胞外蛋白酶活性的多重生物分析技术。本研究展示了一种基于活性的电化学生物传感器,用于检测人血清中经中性缓冲液稀释的组织蛋白酶 B 活性。通过交流伏安法同时在九个通道上测量 200×200μm 微电极上功能化的铁标记肽底物的蛋白水解。蛋白酶活性由指数衰减时间常数的倒数(1/τ)表示,根据米氏-门坦模型,该常数等于[CB] / [S]。在 pH = 7.4 的低离子强度磷酸盐缓冲液中观察到重组人组织蛋白酶 B(rhCB)的活性增强,其活性的检测限非常低,为 8.49×10 s,活性 rhCB 浓度的检测限为 57.1 pM,与基于亲和力的酶联免疫吸附测定(ELISA)相当。通过 ELISA 验证了人血清样本中的组织蛋白酶 B,ELISA 主要检测无活性的前酶,而电化学生物传感器则特异性地测量活性组织蛋白酶 B,并且当 rhCB 和人血清被激活时,显示出明显更高的衰减率。用加标活性组织蛋白酶 B 对人血清进行的动力学电化学测量分析进一步评估了复杂样本中的蛋白酶活性。本研究为开发用于快速检测细胞外蛋白酶活性的金微电极阵列奠定了基础,以用于癌症诊断和治疗评估。